News

Eli Lilly: Analyzing the Latest Trends in Options Trading

Eli Lilly: Analyzing the Latest Trends in Options Trading

Understanding Eli Lilly's Recent Options Market Dynamics

In an interesting turn of events, Eli Lilly has captured the attention of financial analysts and traders alike. Recent analysis of the options history for Eli Lilly (LLY) indicates that 43 unusual trades have emerged, pointing to a notable shift in market sentiment.

Diving deeper into these trades, we found that 44% of traders exhibited a bullish attitude towards Eli Lilly, while 32% leaned bearish. Among the trades identified, 6 were puts valued at $336,908 and a substantial 37 were calls worth a remarkable $4,614,623.

What Are Expert Price Targets?

The latest trading activities suggest that prominent investors are eyeing a price range between $450.0 and $1040.0 for Eli Lilly in the upcoming months. This range highlights the diverse opinions regarding the stock's future direction.

Analyzing Volume and Open Interest

Currently, the average open interest for Eli Lilly options stands at 350.29, with a total trading volume of 1,947.00. The accompanying analysis charts showcase the trends in both call and put options, as well as the open interest, all situated within the strike price corridor of $450.0 to $1040.0 for the past 30 days, illustrating the evolving landscape of options trading.

Last Month's Options Activity Breakdown

In the last month, significant data has emerged from Eli Lilly's options activity.

Notable Options Trades Recently Identified:

Let’s take a look at some of the most significant options trades detected recently:

  • Symbol: LLY, Type: CALL, Trade Type: SWEEP, Sentiment: BULLISH, Exp. Date: 01/17/25, Strike Price: $500.00, Total Price: $2.8M, Volume: 140
  • Symbol: LLY, Type: CALL, Trade Type: TRADE, Sentiment: BEARISH, Exp. Date: 02/21/25, Strike Price: $900.00, Total Price: $163.7K, Volume: 21
  • Symbol: LLY, Type: CALL, Trade Type: TRADE, Sentiment: BULLISH, Exp. Date: 12/20/24, Strike Price: $1020.00, Total Price: $122.7K, Volume: 312
  • Symbol: LLY, Type: PUT, Trade Type: SWEEP, Sentiment: BULLISH, Exp. Date: 11/08/24, Strike Price: $900.00, Total Price: $102.1K, Volume: 33
  • Symbol: LLY, Type: CALL, Trade Type: SWEEP, Sentiment: BEARISH, Exp. Date: 11/01/24, Strike Price: $700.00, Total Price: $82.2K, Volume: 4

A Closer Look at Eli Lilly

Eli Lilly stands out as a prominent player in the biotechnology sector, focusing on areas such as neuroscience, cardiometabolic conditions, oncology, and immunology. Key products from Eli Lilly include Verzenio for cancer treatment; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for managing cardiovascular health; and Taltz and Olumiant for treating autoimmune diseases.

Given the recent trading activity surrounding Eli Lilly, it's vital to assess its current standing in the market.

Current Insights on Eli Lilly's Position

  • Currently trading at $906.86 with a volume of 454,406, LLY has seen an increase of 1.26%.
  • Relative Strength Indicator (RSI) suggests that the stock may be nearing overbought territory.
  • Upcoming earnings reports are anticipated within a day.

Expert Insights on Eli Lilly

Recently, four industry analysts evaluated Eli Lilly and proposed an average price target of $1102.0, reflecting confidence in the company’s market position.

Tracking Unusual Options Activity: A Guide for Investors

Investors today must remain vigilant, especially with unusual options activity signaling potential market movements. By being alert to significant trades, savvy traders can stay one step ahead of market trends.

For those wishing to delve deeper into real-time alerts regarding Eli Lilly's options trades, it’s beneficial to follow relevant updates to adapt trading strategies that align with market changes.

Frequently Asked Questions

What type of options trades has Eli Lilly seen recently?

Recently, Eli Lilly has experienced unusual bullish and bearish options trades indicating varied market sentiment.

What price range are investors targeting for Eli Lilly?

Investors are targeting a price range between $450.0 and $1040.0 for Eli Lilly based on recent trading activity.

How is Eli Lilly performing in the market currently?

Eli Lilly has seen a stock price increase of 1.26%, currently trading at $906.86 with strong trading volume.

What products does Eli Lilly offer?

Eli Lilly offers a variety of products focusing on cancer, cardiometabolic health, and immunology, including Verzenio, Mounjaro, and Trulicity.

How many analysts are covering Eli Lilly?

Currently, four industry analysts are covering Eli Lilly, providing an average target price of $1102.0.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AT&T's Dec. 8 UBS Chat Puts Stankey's Updates on Watch

Updated Category News Views 131

A Small Slot With a Big Audience A calendar entry can still matter when the man holding the microphone runs AT&T. John Stankey, AT&T chairman and chief executive, is scheduled for a fireside chat at the UBS Global Media and Communications Conference on Tuesday, Dec. 8, beginning at 8:15 a.m. Eastern time. The company says the event will be webcast live through its...

Continue Reading
Software-Defined Cars Put $310 Billion in Play by 2035

Updated Category News Views 100

Cars are becoming rolling computers, and that changes who gets paid. Market Growth Reports projects the software-defined vehicle market will rise from $56.94 billion to $310.46 billion by 2035, a 20.74% compound annual growth rate. That is a loud number, no question. Still, investors ought to treat any long-range market forecast like a map, not a mortgage deed. The...

Continue Reading
Qiandaohu Whisky Film Puts Craft Before Market Hype

Updated Category News Views 59

Three Distillers, One Very Large Question Whisky does not become world-class because a camera crew found a pretty shoreline. That is the blunt truth sitting underneath this Nov. 19, 2026 documentary release from CCTV+. The film follows three international distillers working at three separate whisky distilleries along Qiandaohu, while also lingering on their day-to-day...

Continue Reading
CCTV-4 Revisits China's Enduring Academy Tradition

Updated Category News Views 12

Stone courtyards, old books and hard questions are getting prime time on CCTV-4, which is a more interesting programming bet than it may first appear. Enduring Chinese Academies, a ten-episode cultural exploration series from China Media Group's Global Chinese Programming Center, is built around a simple theme: “One academy, one spirit.” It begins airing November 22...

Continue Reading
Eight O'Clock Adds Blonde Roast Pods to Its Lineup

Updated Category News Views 144

A lighter cup of coffee just became Eight O'Clock Coffee's newest swing at the single-serve shelf. On Nov. 19, 2026, the company said it introduced Blonde Roast K-Cup pods, a bright and smooth option aimed at drinkers who prefer a lighter roast. The product is available through Keurig.com and Amazon. That is the whole announcement, and frankly it is better to keep it that...

Continue Reading
Mile High Labs Moves CBD Isolate Into FDA DMF Pathway

Updated Category News Views 76

A Quiet Filing With Real Commercial Weight Cannabis headlines usually arrive wearing a clown suit; this one showed up with paperwork. Mile High Labs says it filed Type II Drug Master File No. 044151 with the U.S. Food and Drug Administration for a 98% CBD isolate on October 2, 2026. That is not a product approval, not permission to market a CBD drug, and certainly not a...

Continue Reading
Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 113

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
GomSpace's €8M Lunar Deal Pushes Mission Ambitions

Updated Category News Views 63

Moon hardware is where small-space dreams either grow teeth or chew through cash, and GomSpace has just taken another meaningful bite. The company has secured an €8 million, or 89.1 million Swedish kronor, contract for the second phase of a lunar mission program with an unnamed leading North American space company. For GOMX, this is not some vague laboratory...

Continue Reading
RADINA Targets Imaging’s Costly Workflow Handoffs Head-On

Updated Category News Views 59

Radiology’s hidden tax is all the chasing, checking, calling, and rechecking between a referral and a completed follow-up. RADIN Health is putting a big claim on the table with RADINA: one autonomous AI ecosystem meant to steer that whole imaging journey rather than merely digitize another isolated chore. The platform is scheduled for its official unveiling at RSNA...

Continue Reading
Northstar's December Test: Metrics Over More Promises

Updated Category News Views 43

A shingle recycler earns its stripes when the machinery behaves, not when the slide deck does. Northstar Clean Technologies is putting Empower Calgary under a brighter light on December 1, pairing its third-quarter 2026 results with a comprehensive production update and a new set of operating metrics. For shareholders, especially those following OTCQB:ROOOF, this is the...

Continue Reading

Top 5 Most Recently Viewed Articles

Latest Copper Drill Results Fuel Optimism for Osisko Metals

Updated Category News Views 144

Exciting New Developments from Osisko Metals Osisko Metals Incorporated, a key player in the exploration and development of critical metals, has announced some thrilling drilling results from the Gaspé Copper Project. This project, known for its significant copper deposits, is located in Eastern Québec and has shown remarkable potential in recent months. Drilling...

Continue Reading
Reel Power's Latest Acquisition Expands Downstream Capabilities

Updated Category News Views 355

Reel Power Boosts Capabilities with New Equipment Acquisition Reel Power has taken a significant step in the industry by acquiring downstream extrusion equipment. This pivotal addition enhances its capabilities, reinforcing its position as a leader in innovative solutions within the material handling sector. By integrating advanced equipment from a reputable manufacturer,...

Continue Reading
Ericsson's Buyback Boost: 2.7 Million Shares Bought

Updated Category News Views 35

Ericsson Dives Deep into Buybacks June doesn't just bring the heat; it brought Ericsson splashing some serious cash into own shares, scooping up a hefty 2.7 million of them over a stretch from June 8th to 12th, 2026. We're talking SEK 308,885,190 spent in this meticulously orchestrated dance of buybacks. This isn't just about gobbling up stocks for funsies. With eyes on...

Continue Reading
altafiber Partners with Main Street Sports for FanDuel Access

Updated Category News Views 189

altafiber and Main Street Sports Group Collaboration altafiber has officially partnered with Main Street Sports Group, the owner of FanDuel Sports Network, to enhance the viewing experience for sports fans. This exciting new development will make FanDuel Sports Network Ohio available on altafiber’s Fioptics+ video platform, ensuring that subscribers have access to a...

Continue Reading
HII Showcases Impressive Growth with Third Quarter Results

Updated Category News Views 275

HII Reports Strong Financial Performance HII (NYSE: HII) has announced remarkable results for the third quarter of fiscal 2025, highlighting a commitment to excellence in the defense sector. The company's revenues reached a record-breaking $3.2 billion, signifying a 16.1% increase from the previous year. This growth is attributed to the robust performance of Newport News...

Continue Reading